Prognostic significance of the tumor-stroma ratio: validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy (POP) trial (10854)Tim Dekker, Wilma E. Mesker, Gabi W. van Pelt et al.|Breast Cancer Research and Treatment|2013Cited by 155